Position history for BlackRock, Inc.'s holdings in BIOCRYST PHARMACEUTICALS INC
BlackRock, Inc. holds 22.7M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $215.6M as of 2026-Q1. The position was increased (+7.2% shares). BCRX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$215.6M
Current Shares
22.7M
Total Value Change
+$49.5M
Total Shares Change
+555,825
Other major holders of BCRX: BAKER BROS. ADVISORS LP, VANGUARD GROUP INC
Increased |
| 22.7M |
+7.2% |
| $215.6M |
| 0.0% |
| $8.69 |
33 |
| 2025-Q4 | Decreased | 21.1M | -0.5% | $164.9M | 0.0% | $7.66 | 0 |
| 2025-Q3 | Decreased | 21.2M | -0.8% | $161.3M | 0.0% | $7.55 | 0 |
| 2025-Q2 | Decreased | 21.4M | -5.9% | $192M | 0.0% | $9.36 | 0 |
| 2025-Q1 | Increased | 22.8M | +3.0% | $170.8M | 0.0% | $7.86 | 31 |
| 2024-Q4 | New | 22.1M | - | $166.2M | 0.0% | $7.53 | 42 |